One-step impedimetric NT-proBNP aptasensor targeting cardiac insufficiency in artificial saliva.

Artificial saliva Cardiac insufficiency Electrochemical impedance spectroscopy Label-free aptasensor N-terminal pro b-type natriuretic peptide

Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 May 2023
Historique:
received: 15 11 2022
revised: 16 01 2023
accepted: 17 01 2023
pubmed: 26 1 2023
medline: 22 2 2023
entrez: 25 1 2023
Statut: ppublish

Résumé

Currently, sensitive and accurate approaches for diagnosis, rapid assessment, and cardiac biomarker monitoring in patients with heart failure are needed. In this context, the advantages of aptamers over traditional antibodies have been employed to fabricate a single-step impedimetric N-terminal pro b-type natriuretic peptide (NT-proBNP)-modified gold microelectrode array. The development of an electrochemical aptasensing platform was based on the coimmobilization of alkanethiol self-assembled monolayers and amine-terminated aptamer that specifically recognized cardiac NT-proBNP protein resulting in charge electron transfer. Electroimpedimetric signals of the sensor were observed to be linear to the NT-proBNP concentrations in the range of 5.0 × 10

Identifiants

pubmed: 36696735
pii: S0039-9140(23)00031-0
doi: 10.1016/j.talanta.2023.124280
pii:
doi:

Substances chimiques

pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0
Saliva, Artificial 0
Peptide Fragments 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124280

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Waralee Ruankham (W)

Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand.

Isaac Aarón Morales Frías (IA)

Institut des Sciences Analytiques (ISA), Université Claude Bernard Lyon-1, Lyon, 69100, France.

Kamonrat Phopin (K)

Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand; Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand.

Tanawut Tantimongcolwat (T)

Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Bangkok, 10700, Thailand.

Joan Bausells (J)

Instituto de Microelectrónica de Barcelona (IMB-CNM-CSIC), Campus Universitat Autònoma de Barcelona (UAB), Barcelona, 08193, Spain.

Nadia Zine (N)

Institut des Sciences Analytiques (ISA), Université Claude Bernard Lyon-1, Lyon, 69100, France.

Abdelhamid Errachid (A)

Institut des Sciences Analytiques (ISA), Université Claude Bernard Lyon-1, Lyon, 69100, France. Electronic address: abdelhamid.errachid-el-salhi@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH